NCT06781411

Brief Summary

Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
602mo left

Started Nov 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Nov 2024Nov 2075

Study Start

First participant enrolled

November 6, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 13, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 17, 2025

Completed
50.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 6, 2075

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2075

Last Updated

January 17, 2025

Status Verified

January 1, 2025

Enrollment Period

51 years

First QC Date

January 13, 2025

Last Update Submit

January 13, 2025

Conditions

Tissue Banking

Keywords

tissuedonatesurgerybiobank

Outcome Measures

Primary Outcomes (1)

  • Receipt of donated human tissue for research

    The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.

    50 years

Study Arms (1)

Donated Human Tissue

This Project will receive discarded human tissue from consented participants. For the purposes of this project, human tissue is defined as any bodily material collected from a human person, including bone marrow, skin, tumors, etc., through a clinical procedure. The clinical procedure will done not be done solely for the purpose of this Project. Participants (donors) will prospectively provide informed consent, complete an online case report form, and donate the unwanted human tissue that results from their surgery/procedure.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will donate unwanted human tissue as a result of surgery.

You may qualify if:

  • be able to read and understand English
  • scheduled for a surgery or procedure that will result in the removal of human tissue.

You may not qualify if:

  • Pregnant
  • unable to provide an informed consent
  • unable to understand or read in English
  • minors (ages under 18)
  • prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Central Florida

Orlando, Florida, 32827, United States

RECRUITING

Central Study Contacts

Britney-Ann Wray, BS, CTBS, CCRP

CONTACT

4072668742britney-ann.wray@ucf.edu

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2025

First Posted

January 17, 2025

Study Start

November 6, 2024

Primary Completion (Estimated)

November 6, 2075

Study Completion (Estimated)

November 6, 2075

Last Updated

January 17, 2025

Record last verified: 2025-01

Locations

US(1)